ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 14 Apr 2014
Last Applicant/ Owned by
909 Third Avenue
New York
NY
10022
Serial Number
85404125 filed on 22nd Aug 2011
Registration Number
N/A
Correspondent Address
Christopher Serbagi, Esq.
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
BRYZIM
Pharmaceutical preparations for the treatment of bacterial infections, diabetes, pain, neuropathic pain, diabetic neuropathy, cardiovascular system diseases and disorders, respiratory system diseases and disorders, neurological diseases and disorders, neurodegenerative diseases and disorders, central nervous system diseases and disorders, gastrointestinal diseases and disorders; antidepressants; a Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of bacterial infections, diabetes, pain, neuropathic pain, diabetic neuropathy, cardiovascular system diseases and disorders, respiratory system diseases and disorders, neurological diseases and disorders, neurodegenerative diseases and disorders, central nervous system diseases and disorders, gastrointestinal diseases and disorders; antidepressants; antipsychotics; coronary vasodilating agents
Mark Details
Serial Number
No 85404125
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 14th Apr 2014 | ABANDONMENT - NO USE STATEMENT FILED |
| 14th Apr 2014 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 30th Aug 2013 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 29th Aug 2013 | EXTENSION 3 GRANTED |
| 28th Aug 2013 | TEAS EXTENSION RECEIVED |
| 28th Aug 2013 | EXTENSION 3 FILED |
| 26th Mar 2013 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 25th Mar 2013 | EXTENSION 2 GRANTED |
| 25th Mar 2013 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 06th Mar 2013 | EXTENSION 2 FILED |